Insider Selling: PACS Group (NYSE:PACS) Director Sells 155,682 Shares

PACS Group, Inc. (NYSE:PACS) Director Mark Hancock sold 155,682 shares of the company’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $42.47, for a total value of $6,611,814.54. Following the completion of the transaction, the director directly owned 53,518,884 shares in the company, valued at approximately $2,272,947,003.48. The trade was a 0.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

• On Monday, September 14th, Mark Hancock sold 144,318 shares of PACS Group stock. The shares were sold at an average price of $44.57, for a total value of $6,432,253.26.
• On Thursday, July 9th, Mark Hancock sold 4,966 shares of PACS Group stock. The shares were sold at an average price of $45.06, for a total value of $223,767.96.
• On Wednesday, July 8th, Mark Hancock sold 20,338 shares of PACS Group stock. The shares were sold at an average price of $45.07, for a total value of $916,633.66.
• On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The stock was sold at an average price of $45.33, for a total value of $6,444,248.79.
• On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The shares were sold at an average price of $45.01, for a total transaction of $577,253.25.
• On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The shares were sold at an average price of $45.02, for a total transaction of $273,721.60.
• On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The stock was sold at an average price of $40.50, for a total transaction of $2,508,205.50.
• On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The shares were sold at an average price of $40.33, for a total transaction of $5,568,322.77.
• On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The stock was sold at an average price of $35.31, for a total transaction of $2,248,540.80.

PACS Group Stock Down 5.7%

NYSE PACS traded down $2.54 during trading on Tuesday, hitting $42.01. 1,011,870 shares of the company traded hands, compared to its average volume of 905,184. PACS Group, Inc. has a 12 month low of $10.31 and a 12 month high of $49.49. The business has a fifty day simple moving average of $44.74 and a 200 day simple moving average of $39.12. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $6.65 billion, a P/E ratio of 24.42, a PEG ratio of 1.40 and a beta of -0.13.

PACS Group (NYSE:PACS) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. As a group, sell-side analysts predict that PACS Group, Inc. will post 2.13 EPS for the current year.

Wall Street Analysts Forecast Growth

PACS has been the subject of a number of analyst reports. UBS Group boosted their price objective on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Truist Financial set a $62.00 target price on shares of PACS Group in a report on Wednesday, September 2nd. Royal Bank Of Canada lifted their target price on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, August 6th. Weiss Ratings lowered shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, August 5th. Finally, Oppenheimer upped their price target on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.80.

Trending Headlines about PACS Group

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Investor Steven Cress highlighted PACS Group as a highly rated stock he owns, reinforcing the bullish case for the skilled-nursing and post-acute-care operator. Behind The Portfolio: Why Steven Cress Owns This Top-Rated Stock
• Positive Sentiment: Analyst sentiment remains favorable: PACS has a consensus “Moderate Buy” rating and an average price target of $58.80, above recent trading levels. Truist, Oppenheimer, UBS and JPMorgan have recently set targets ranging from $57 to $62. The company also exceeded second-quarter earnings and revenue expectations, reporting adjusted earnings of $0.63 per share versus the $0.54 consensus and revenue of $1.43 billion versus $1.41 billion.
• Neutral Sentiment: PACS announced that CEO and Chairman Jason Murray, CFO Carey Hendrickson and COO Josh Jergensen will present at the Jefferies Healthcare Services and Technology Conference on September 15. Investors may look for updates on operations, growth plans and the company’s outlook. PACS Group to Present at the 2026 Jefferies Healthcare Services and Technology Conference
• Negative Sentiment: CEO Jason Murray continued selling shares under a pre-arranged Rule 10b5-1 plan, including 317 shares at $45.03 and earlier sales of 10,529 shares at $45.23 and 8,771 shares at $45.16. The sales can weigh on sentiment, although they represent a very small portion of his roughly 54.6 million remaining shares and do not necessarily signal deteriorating business prospects. Insider Selling: PACS Group CEO Sells 317 Shares

Hedge Funds Weigh In On PACS Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its holdings in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after purchasing an additional 614,250 shares during the period. 8 Knots Management LLC bought a new position in shares of PACS Group during the 4th quarter worth about $23,421,000. Sei Investments Co. increased its holdings in shares of PACS Group by 7.4% during the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock worth $11,900,000 after purchasing an additional 25,462 shares during the period. Arrowstreet Capital Limited Partnership raised its position in shares of PACS Group by 44.6% during the first quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after buying an additional 89,067 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in shares of PACS Group during the second quarter valued at about $8,196,000.

PACS Group Company Profile

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.